Everyone's favorite heartless pharma CEO is at it again

Remember Martin Shkreli? You know, the guy who tried to raise the price of a life-saving cancer and AIDS drug by 5000 percent and then took a precious Wu-Tang Clan album off the market forever? Well, he’s at it again!

From Saturday’s New York Times:

Martin Shkreli is once again provoking alarm with a plan to sharply increase the price of a decades-old drug for a serious infectious disease. This time the drug treats Chagas disease, a parasitic infection that can cause potentially lethal heart problems.

Shkreli’s company, KaloBios, bought the drug, called Benznidazole, last week. Reuters reports that it is “approved in Latin America as the standard of care for Chagas disease.”

Where some might see a way to further assist a poorer population, though, Martin Shkreli apparently sees a nice big profit. According to the Times, he told that investors the price of his newly purchased drug “would be similar to that of hepatitis C drugs, which cost $60,000 to nearly $100,000 for a course of treatment.” Currently, Benznidazole costs between $50 and $100.

If Shkreli was at all embarrassed about this, he didn’t show it on Twitter. Here’s how he responded to former Obama adviser David Axelrod’s criticism of him:

@davidaxelrod it’s called a pharmaceutical company. Shame on you for your intellectual dishonesty.

— Martin Shkreli (@MartinShkreli) December 12, 2015

What a guy! Reports that he is currently developing a fool-proof method of taking candy from babies reliably and efficiently, and then figure out how to do away with sunlight, are unconfirmed.